Study Stopped
Difficulty getting labs in this setting. After pilot study, this study was not continued.
Reexamining Hypotonic Intravenous Fluid Use
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The study aim is to isolate a single type of patient (pediatric patient with acute gastrointestinal symptoms) and evaluate the use of hypotonic (0.45 NS) vs. isotonic (0.9 NS) fluids in these patients in regards to changes in their serum sodium and iatrogenic hyponatremia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Oct 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2014
CompletedFirst Submitted
Initial submission to the registry
October 13, 2014
CompletedFirst Posted
Study publicly available on registry
January 29, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2016
CompletedJanuary 29, 2016
January 1, 2016
1.7 years
October 13, 2014
January 26, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in sodium
8 hours
Study Arms (2)
Group 1
ACTIVE COMPARATORThese patients will receive Dextrose 5% and 0.9 NS in their maintenance IV fluids
Group 2
ACTIVE COMPARATORThese patients will receive Dextrose 5% and 0.45 NS in their maintenance IV fluids
Interventions
Eligibility Criteria
You may qualify if:
- Children 6 months to 16 years of age
- Symptoms of acute gastroenteritis (acute vomiting and/or diarrhea; symptoms of the "stomach flu")
- Admission to the hospital
- Requiring maintenance IVF as determined by the inpatient attending clinical judgment.
You may not qualify if:
- Age \<6 months or age \>16 years
- Weight \>60 kg
- Admission to the PICU
- Chronic kidney disease
- Endocrine disorders
- Liver or heart disease
- Malignancies
- Human immunodeficiency virus
- Cystic fibrosis
- Epilepsy
- Guillan Barre Syndrome
- Multiple sclerosis.
- Any diuretic medications or medication known to affect ADH secretion
- Abnormal baseline sodium concentration (\<133 mEq/L or \> 147 mEq/L)
- Abnormal baseline systolic blood pressure (\>95% based on age and height normative values)
- +6 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ann and Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, 60611, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Waheeda Samady, MD
Lurie Children's Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Pediatric Hospitalist
Study Record Dates
First Submitted
October 13, 2014
First Posted
January 29, 2016
Study Start
October 1, 2014
Primary Completion
June 1, 2016
Study Completion
June 1, 2016
Last Updated
January 29, 2016
Record last verified: 2016-01